NEUROONE MEDICAL TECHNOLOGIES Corp — Director's Dealing 2017

Jul 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEUROONE MEDICAL TECHNOLOGIES Corp (OSOK)
CIK: 0001500198
Period of Report: 2017-07-20

Reporting Person: Christianson Mark (VP, Business Dev and Marketing, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-20	Common Stock	A	1423206	—	Acquired	1423206	Direct

Footnotes

F1: The reporting person acquired the shares of NeuroOne Medical Technologies Corporation ("NMTC") on July 20, 2017, in exchange for shares of the common stock of NeuroOne, Inc. ("NeuroOne"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of July 20, 2017, between NMTC, OSOK Acquisition Company and NeuroOne, pursuant to which NeuroOne became the wholly-owned subsidiary of NMTC. Per the terms of the Merger Agreement, each share of NeuroOne common stock was converted into the right to receive 17.0103706 shares of NMTC common stock.